Completed NA INTERVENTIONAL 1-arm NCT04099043

Cascade CGM 15-day Performance Assessment (CASPA)

Cascade Continuous Glucose Monitor 15-day Performance Assessment

Sponsor: WaveForm Technologies Inc.

Conditions Continuous Glucose Monitoring

Interventions Cascade Continuous Glucose Monitoring System

Updated 5 times since 2019 Last updated: Apr 2, 2020 Started: Sep 28, 2019 Primary completion: Oct 13, 2019 Completion: Oct 13, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04099043, this NA trial focuses on Continuous Glucose Monitoring and remains completed. Sponsored by WaveForm Technologies Inc., it has been updated 5 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
May 2020 — Jan 2021 [monthly]

Completed NA

Status: Not Yet Recruiting → Completed
Oct 2019 — May 2020 [monthly]

Not Yet Recruiting NA

First recorded

Sep 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

WaveForm Technologies Inc.

Data source: WaveForm Technologies Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Celje, Slovenia